XNCR
Xencor Inc
NASDAQ: XNCR · HEALTHCARE · BIOTECHNOLOGY
$11.93
+2.67% today
Updated 2026-04-30
Market cap
$861.36M
P/E ratio
—
P/S ratio
6.86x
EPS (TTM)
$-1.24
Dividend yield
—
52W range
$7 – $19
Volume
0.9M
Xencor Inc (XNCR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.08M | $-11.05M | $-5.45M | $-21.35M | $26.67M | $94.62M | $-33.68M | $-79.76M | $64.37M | $-5.00M | $-16.85M | $24.48M | $85.11M | $-202.19M | $-135.12M |
| Capital expenditures | $1.42M | $1.26M | $1.29M | $2.29M | $3.67M | $3.01M | $7.28M | $9.15M | $11.04M | $13.77M | $15.98M | $43.40M | $21.25M | $6.10M | $3.15M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $-57000.00 | $29000.00 | $198000.00 | $1.86M | $4.87M | $7.85M | $13.65M | $20.55M | $31.85M | $31.62M | $36.98M | $48.91M | $53.76M | $53.28M | $43.23M |
| Free cash flow | $-2.50M | $-12.31M | $-6.75M | $-23.64M | $22.99M | $91.61M | $-40.96M | $-88.90M | $53.34M | $-18.77M | $-32.83M | $-18.92M | $63.86M | $-208.28M | $-138.27M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-23.33M | $-42.06M | $1.94M | $2.00M | $9.72M | $24.07M | $113.23M | $-20.06M | — | — | — | — |